Loading institutional data...
Loading institutional data...
Held by 375 of 6,047 reporting institutions (95th percentile) — extremely crowded.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $74.29 today, the market must believe free cash flow compounds -2.8%/yr for a decade (off $397.7M on the 3-yr avg basis).
On the basis ($374.7M) the requirement is -2.0%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's -2.8% is more conservative than its 9-yr track record.
Default is 8.6% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.05B shares (market data) · net debt $612.0M
mean -36.7% · volatility σ 112% · implied rate exceeded in 3/8 yrs
Central path = implied -2.8%/yr growth; shaded band = ±1σ (112%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 25% of free cash flow, leaving room to grow it and fund buybacks. Last year: $96.0M dividends + $168.0M buybacks = $264.0M returned on $391.0M FCF.
4 consecutive years of dividend increases · 6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 14%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-16
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.71B 100.0% | $3.99B 100.0% | $3.93B 100.0% | $4.32B 100.0% | $3.41B 100.0% | $2.61B 100.0% | $3.34B 100.0% | $3.24B 100.0% | $2.72B 100.0% | $2.41B 100.0% |
| Cost of Revenue | $2.77B 74.7% | $3.03B 76.0% | $3.09B 78.7% | $3.44B 79.5% | $2.61B 76.6% | $2.11B 80.9% | $2.65B 79.5% | $2.47B 76.2% | $2.06B 75.8% | $1.84B 76.2% |
| Gross Profit | $940.0M 25.3% | $960.0M 24.0% | $839.0M 21.3% | $885.0M 20.5% | $799.0M 23.4% | $500.0M 19.1% | $685.0M 20.5% | $772.0M 23.8% | $657.0M 24.2% | $575.0M 23.8% |
| Research & Development | $59.0M 1.6% | $63.0M 1.6% | $57.0M 1.5% | $55.0M 1.3% | $56.0M 1.6% | $57.0M 2.2% | $60.0M 1.8% | $66.0M 2.0% | $57.0M 2.1% | $53.0M 2.2% |
| Selling, General & Admin | $260.0M 7.0% | $283.0M 7.1% | $253.0M 6.4% | $258.0M 6.0% | $289.0M 8.5% | $292.0M 11.2% | $290.0M 8.7% | $308.0M 9.5% | $262.0M 9.6% | $275.0M 11.4% |
| Operating Income | $621.0M 16.7% | $614.0M 15.4% | $526.0M 13.4% | $389.0M 9.0% | $454.0M 13.3% | $21.0M 0.8% | $306.0M 9.2% | $144.0M 4.4% | $338.0M 12.4% | $247.0M 10.2% |
| Interest Expense | $76.0M 2.0% | $81.0M 2.0% | $90.0M 2.3% | $56.0M 1.3% | $49.0M 1.4% | $53.0M 2.0% | $59.0M 1.8% | $54.0M 1.7% | $53.0M 2.0% | $54.0M 2.2% |
| Other Income (Expense), net | -$7.0M -0.2% | -$36.0M -0.9% | -$16.0M -0.4% | -$9.0M -0.2% | -$7.0M -0.2% | -$9.0M -0.3% | -$1.0M -0.0% | $17.0M 0.5% | $5.0M 0.2% | -$7.0M -0.3% |
| Pretax Income | $565.0M 15.2% | $529.0M 13.2% | $451.0M 11.5% | $335.0M 7.8% | $406.0M 11.9% | -$33.0M -1.3% | $255.0M 7.6% | $117.0M 3.6% | $299.0M 11.0% | $191.0M 7.9% |
| Income Tax Expense | $196.0M 5.3% | $111.0M 2.8% | -$28.0M -0.7% | $102.0M 2.4% | $123.0M 3.6% | $191.0M 7.3% | $70.0M 2.1% | $193.0M 6.0% | $33.0M 1.2% | $33.0M 1.4% |
| Net Income | $331.0M 8.9% | $380.0M 9.5% | $445.0M 11.3% | $209.0M 4.8% | $250.0M 7.3% | -$238.0M -9.1% | $157.0M 4.7% | -$113.0M -3.5% | $248.0M 9.1% | $147.0M 6.1% |
| Per Share | ||||||||||
| EPS (Basic) | $6.07 | $6.79 | $7.79 | $3.65 | $4.35 | -$4.21 | $2.64 | -$1.85 | $3.94 | $2.34 |
| EPS (Diluted) | $6.02 | $6.72 | $7.73 | $3.62 | $4.34 | -$4.21 | $2.63 | -$1.85 | $3.91 | $2.32 |
| Weighted Avg Shares (Basic) | 53.7M | 55.1M | 56.1M | 56.5M | 56.7M | 56.6M | 58.7M | 61.7M | 62.3M | 62.4M |
| Weighted Avg Shares (Diluted) | 54.2M | 55.7M | 56.5M | 56.9M | 56.8M | 56.6M | 58.8M | 61.7M | 62.7M | 62.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-16
Where each multiple sits in its own 14-yr range · 49th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 21% against ROIC 14% — 8% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 76.2 | 79.5 | 80.9 | 76.6 | 79.5 | 78.7 | 76.0 | 74.7 |
| Gross Profit | 23.8 | 20.5 | 19.1 | 23.4 | 20.5 | 21.3 | 24.0 | 25.3 |
| R&D | 2.0 | 1.8 | 2.2 | 1.6 | 1.3 | 1.5 | 1.6 | 1.6 |
| SG&A | 9.5 | 8.7 | 11.2 | 8.5 | 6.0 | 6.4 | 7.1 | 7.0 |
| Operating Income | 4.4 | 9.2 | 0.8 | 13.3 | 9.0 | 13.4 | 15.4 | 16.7 |
| Income Tax | 6.0 | 2.1 | 7.3 | 3.6 | 2.4 | -0.7 | 2.8 | 5.3 |
| Net Income | -3.5 | 4.7 | -9.1 | 7.3 | 4.8 | 11.3 | 9.5 | 8.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CBT: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $258.0M covers the $254.0M due within a year 1.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-09-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~8.7% on $870.0M of debt.
Cash of $258.0M fully covers short-term debt of $14.0M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Earns 12.79pts above its cost of capital, positive in 5 of the last 5 years.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 13.1% | 8.6% (today's — no rate published for this year) | 4.4pts |
| FY2020 | 1.0% | 8.6% (today's — no rate published for this year) | -7.7pts |
| FY2021 | 21.4% | 7.8% | 13.7pts |
| FY2022 | 13.9% | 8.4% | 5.5pts |
| FY2023 | 17.6% | 8.9% | 8.7pts |
| FY2024 | 20.2% | 8.2% | 11.9pts |
| FY2025 | 21.9% | 8.4% | 13.6pts |
| Now | 13.7% | 8.6% | 5.0pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 23.8% | 10.2% | 6.1% |
| FY2017 | 24.2% | 12.4% | 9.1% |
| FY2018 | 23.8% | 4.4% | -3.5% |
| FY2019 | 20.5% | 9.2% | 4.7% |
| FY2020 | 19.1% | 0.8% | -9.1% |
| FY2021 | 23.4% | 13.3% | 7.3% |
| FY2022 | 20.5% | 9.0% | 4.8% |
| FY2023 | 21.3% | 13.4% | 11.3% |
| FY2024 | 24.0% | 15.4% | 9.5% |
| FY2025 | 25.3% | 16.7% | 8.9% |
Leverage and buybacks account for 8 points of the 21% return on equity in FY2025. The business earns 14% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$137M of goodwill — 6% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Cash conversion of 0.57x sits below the level that would make the earnings clearly cash-backed.
The cash conversion cycle could not be computed — receivables, inventory or cost of revenue is not reported — so the earliest accrual warning is not part of this verdict.
Covers interest 5.7x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 8.17x |
| 5% | 7.76x |
| 10% | 7.35x |
| 15% | 6.95x |
| 20% | 6.54x |
| 25% | 6.13x |
| 30% | 5.72x |
| 35% | 5.31x |
| 40% | 4.90x |
| 45% | 4.49x |
| 50% | 4.09x |
| 55% | 3.68x |
| 60% | 3.27x |
Ladder as of 2025-09-30 (10-K); cash from the 2025-09-30 balance sheet; FCF from FY2025.
Balance sheet at 2025-09-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $74.29, free cash flow must compound -2.43%/yr for 10 years. It has done 18.81%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 27.3% | −2.4% |
| FY2021 | −65.0% | −2.4% |
| FY2022 | −279.0% | −2.4% |
| FY2024 | 28.5% | −2.4% |
| FY2025 | −13.3% | −2.4% |
The implied rate has been matched or beaten in 2 of the last 5 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $331M | $331M |
| Share-based comp | $24M | $355M |
| Other non-cash & working capital | $310M | $665M |
| Operating cash flow | $665M | $665M |
| Capex | −$274M | $391M |
| Free cash flow | $391M | $391M |
| FCF after SBC | $367M | $367M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -21.7% | not reported | not reported |
| FY2021 | 30.4% | not reported | not reported |
| FY2022 | 26.8% | not reported | not reported |
| FY2023 | -9.0% | not reported | not reported |
| FY2024 | 1.6% | not reported | not reported |
| FY2025 | -7.0% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -6.9 percent |
| FY2020 | -22.1 percent |
| FY2021 | -0.2 percent |
| FY2022 | 3.1 percent |
| FY2023 | -4.2 percent |
| FY2024 | -8.3 percent |
| FY2025 | -8.8 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.